UroMems Initiates First-in-Human Study of Its Smart Implant
UroMems, a global company developing breakthrough, mechatronics technology to treat stress urinary incontinence (SUI), that it has successfully completed.
UroMems, a global company developing breakthrough, mechatronics technology to treat stress urinary incontinence (SUI), that it has successfully completed.
Opteev Technologies, Inc. it has developed an affordable breath analyzer, ViraWarn, that detects COVID-19, Influenza, and RSV in less than 60 seconds.
ulrich medical USA, Inc., a privately held medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States.
Phagenesis Ltd, that the U.S. Food and Drug Administration (FDA) has granted a De Novo request for the Phagenyx® Neurostimulation System.
Crown Aesthetics ("Crown"), a division of Crown Laboratories and inventors of the award-winning SkinPen Precision, that its revolutionary device has received three new approved indications in the EU and UK.
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") that it has executed a binding Term Sheet ("Term Sheet" or "Agreement") with Procare Health Iberia, S.L.
HistoSonics,the developer and manufacturer of a completely non-invasive platform and proprietary sonic beam therapy.
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, the market launch of the Guardenia™ Contained Extraction System.
Crown Aesthetics ("Crown"), a division of Crown Laboratories, Inc.,that its direct United Kingdom and Ireland ("UKI") team will now offer all UK & Ireland.
Healium Medical ("Healium"), innovating a proprietary Dual-Mode Ultrasound Technology (DMUT) for the treatment of cardiac arrhythmias a new collaboration and licensing agreement with Broncus Holding Corporation (2216.HK; "Broncus").